日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

BRIDGE-DS study: evaluating the effectiveness and safety of dapagliflozin/sitagliptin combination in type 2 diabetes mellitus patients with heart failure

BRIDGE-DS 研究:评估达格列净/西格列汀联合疗法治疗合并心力衰竭的 2 型糖尿病患者的有效性和安全性

Kumar, Kandanat Purushothaman Nair Suresh; Variam, Manikandan Thiruvanath; S, Bala Vignesh; Nath, Kshitiz; Goyal, Kailash Kumar; Beswal, Gaurav; Arun, Prashanth; Narayan, Kiran; Kumar, S P Sathish; Ravindranath, V; Tripathy, Nishant; Kalra, Bharat Kumar; Ray, Pranabes; Garg, Pooja; Laul, Anil; Dhand, Sunil; Kamat, Sajal; Kesarkar, Rohan Narayan; Prasad, Ashish; Pednekar, Abhijit

BRIDGE-DS study: a multicenter, observational, retrospective analysis of dapagliflozin and sitagliptin combination on modifiable cardiovascular risk factors in T2DM patients with ASCVD or high cardiovascular risk

BRIDGE-DS 研究:一项多中心、观察性、回顾性分析,旨在评估达格列净联合西格列汀治疗对合并动脉粥样硬化性心血管疾病或高心血管风险的 2 型糖尿病患者可改变的心血管危险因素的影响。

Bhamri, Naveen; Kumar, Ashutosh; Mishra, Chandrakant; Devarbhavi, Praveen Kumar; Prasad, Surendra; Rudach, Devanand Samatbhai; Potdar, Anil; Patil, Sachin Narendra; Tewari, Ajoy Kumar; Jagdish, P S; Gayan, Rajib; Bansal, Sunil; Maheshbabu, Chinnakonda R; Asalkar, Amit H; Chitale, Manoj; Kesarkar, Rohan Narayan; Prasad, Ashish; Pednekar, Abhijit

Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo

吡啶甲酸是一种广谱包膜病毒入侵抑制剂,可在体内抑制SARS-CoV-2和甲型流感病毒的入侵。

Rohan Narayan,Mansi Sharma,Rajesh Yadav,Abhijith Biji,Oyahida Khatun,Sumandeep Kaur,Aditi Kanojia,Christy Margrat Joy,Raju Rajmani,Pallavi Raj Sharma,Sharumathi Jeyasankar,Priya Rani,Radha Krishan Shandil,Shridhar Narayanan,Durga Chilakalapudi Rao,Vijaya Satchidanandam,Saumitra Das,Rachit Agarwal,Shashank Tripathi

SARS-CoV-2 ORF6 protein targets TRIM25 for proteasomal degradation to diminish K63-linked RIG-I ubiquitination and type-I interferon induction

SARS-CoV-2 ORF6 蛋白靶向 TRIM25 进行蛋白酶体降解,以减少 K63 关联的 RIG-I 泛素化和 I 型干扰素诱导

Oyahida Khatun, Mansi Sharma, Rohan Narayan, Shashank Tripathi

Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2

针对 Nsp1-核糖体复合物的药物显示出对 SARS-CoV-2 的抗病毒活性

Mohammad Afsar, Rohan Narayan, Md Noor Akhtar, Deepakash Das, Huma Rahil, Santhosh Kambaiah Nagaraj, Sandeep M Eswarappa, Shashank Tripathi, Tanweer Hussain

Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples

通过对鼻咽样本的组学数据进行荟萃分析和验证,确定 COVID-19 预后标记和治疗靶点

Abhijith Biji, Oyahida Khatun, Shachee Swaraj, Rohan Narayan, Raju S Rajmani, Rahila Sardar, Deepshikha Satish, Simran Mehta, Hima Bindhu, Madhumol Jeevan, Deepak K Saini, Amit Singh, Dinesh Gupta, Shashank Tripathi

Cell-penetrating peptide sequence and modification dependent uptake and subcellular distribution of green florescent protein in different cell lines

细胞穿透肽序列和修饰依赖的绿色荧光蛋白在不同细胞系中的吸收和亚细胞分布

Sanjay G Patel, Edward J Sayers, Lin He, Rohan Narayan, Thomas L Williams, Emily M Mills, Rudolf K Allemann, Louis Y P Luk, Arwyn T Jones, Yu-Hsuan Tsai